Active-learning strategies in computer-assisted drug discovery

Drug Discovery Today

Volumn 20, Issue 4, 2015, Pages 458-465

  Reker, Daniel ^a   Schneider, Gisbert ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ALGORITHM; ANIMAL; BIOLOGY; CHEMICAL DATABASE; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER AIDED DESIGN; DRUG DATABASE; DRUG DEVELOPMENT; HUMAN; MOLECULARLY TARGETED THERAPY; PROCEDURES; STRUCTURE ACTIVITY RELATION; SUPERVISED MACHINE LEARNING;

ALGORITHMS; ANIMALS; COMPUTATIONAL BIOLOGY; COMPUTER-AIDED DESIGN; DATABASES, CHEMICAL; DATABASES, PHARMACEUTICAL; DRUG DISCOVERY; HUMANS; MOLECULAR STRUCTURE; MOLECULAR TARGETED THERAPY; PHARMACEUTICAL PREPARATIONS; STRUCTURE-ACTIVITY RELATIONSHIP; SUPERVISED MACHINE LEARNING;

EID: 84930211844     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2014.12.004     Document Type: Review

References (62)

1. G. Schneider, and A. Schüller Adaptive combinatorial design of focused compound libraries Methods Mol. Biol. 572 2009 135 147
2. G. Schneider Voyages to the (un)known: adaptive design of bioactive compounds Trends Biotechnol. 27 2009 18 26
3. P.S. Kutchukian Inside the mind of a medicinal chemist: the role of human bias in compound prioritization during drug discovery PLoS ONE 7 2012 e48476
4. V. Schnecke, and J. Boström Computational chemistry-driven decision making in lead generation Drug Discov. Today 11 2006 43 50
5. B.L. Claus, and D.J. Underwood Discovery informatics: its evolving role in drug discovery Drug Discov. Today 7 2002 957 966
6. J. Singh Application of genetic algorithms to combinatorial synthesis: a computational approach to lead identification and lead optimization J. Am. Chem. Soc. 118 1996 1669 1676
7. P. Willet Chemoinformatics - similarity and diversity in chemical libraries Curr. Opin. Biotechnol. 11 2000 85 88
8. T. Rodrigues Accessing new chemical entities through microfluidic technology Angew. Chem. Int. Ed. 53 2014 5750 5758
9. S.D. Pickett Automated lead optimization of MMP-12 inhibitors using a genetic algorithm ACS Med. Chem. Lett. 2 2011 28 33
10. J. Bajorath Navigating structure-activity landscapes Drug Discov. Today 14 2009 698 705
11. A.L. Hopkins, and A. Polinsky Knowledge and intelligence in drug design Annu. Rep. Med. Chem. 41 2006 425 437
12. B. Settles Active Learning Literature Survey 2010 University of Wisconsin
13. I. Guyon Active Learning Challenge: Challenges in Machine Learning Vol. 6 2012 Microtome Publishing
14. M.K. Warmuth Active learning in the drug discovery process NIPS 2001 1449 1456
15. M.K. Warmuth Active learning with support vector machines in the drug discovery process J. Chem. Inf. Comput. Sci. 43 2003 667 673
16. Y. Fujiwara Virtual screening system for finding structurally diverse hits by active learning J. Chem. Inf. Model. 48 2008 930 940
17. J. Bajorath Integration of virtual and high-throughput screening Nat. Rev. Drug Discov. 1 2002 882 894
18. K. De Grave Active learning for high throughput screening Discovery Science 2008 Springer 185 196
19. K. De Grave Active learning for primary drug screening Benelearn 08, The Annual Belgian-Dutch Machine Learning Conference 2008 55 56 Conference Proceedings; available online at http://www.montefiore.ulg.ac.be/services/stochastic/benelearn08/
20. M. Ahmadi Predicting potent compounds via model-based global optimization J. Chem. Inf. Model. 53 2013 553 559
21. D.M. Negoescu The knowledge-gradient algorithm for sequencing experiments in drug discovery NFORMS J. Comput. 23 2011 346 363
22. R.P. Sheridan Why do we need so many chemical similarity search methods? Drug Discov Today 7 2002 903 911
23. D. Reker Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus Proc. Natl. Acad. Sci. U.S.A. 111 2014 4067 4072
24. Y. Baram Online choice of active learning algorithms J. Mach. Learn. Res. 5 2004 255 291
25. P. Donmez Dual strategy active learning Machine Learning: ECML 2007 2007 Springer 116 127
26. J.L. Medina-Franco Balancing novelty with confined chemical space in modern drug discovery Expert Opin. Drug Discov. 9 2014 151 156
27. L. Weber Evolutionary combinatorial chemistry: application of genetic algorithms Drug Discov. Today 3 1998 379 385
28. L. Weber Optimization of the biological activity of combinatorial compound libraries by a genetic algorithm Angew. Chem. Int. Ed. 34 1995 2280 2282
29. K. Illgen Simulated molecular evolution in a full combinatorial library Chem. Biol. 7 2000 433 441
30. Y. Yokobayashi Directed evolution of trypsin inhibiting peptides using a genetic algorithm J. Chem. Soc., Perkin Trans. 1 20 1996 2435 2439
31. S. Kampenhausen A genetic algorithm for the design of molecules with desired properties J. Comput. Aided Mol. Des. 16 2002 551 567
32. J. Besnard Automated design of ligands to polypharmacology profiles Nature 492 2012 215 220
33. A. Gobbi, and D. Poppinger Genetic optimization of combinatorial libraries Biotechnol. Bioeng. 61 1998 47 54
34. B. Desai Rapid discovery of a novel series of Abl kinase inhibitors by application of an integrated microfluidic synthesis and screening platform J. Med. Chem. 56 2013 3033 3047
35. R. Varela Iterative refinement of a binding pocket model: active computational steering of lead optimization J. Med. Chem. 55 2012 8926 8942
36. 50 data - a statistical analysis PLOS ONE 8 2013 e61007
37. R.D. King Functional genomic hypothesis generation and experimentation by a robot scientist Nature 427 2004 247 252
38. S.C.H. Hoi Batch mode active learning and its application to medical image classification Proceedings of the International Conference on Machine Learning (ICML) 2006 ACM Press 417 424
39. E. Byvatov From virtual to real screening for D3 dopamine receptor ligands ChemBioChem 6 2005 997 999
40. L. Franke Extraction and visualization of potential pharmacophore points using support vector machines: application to ligand-based virtual screening for COX-2 inhibitors J. Med. Chem. 48 2005 6997 7004
41. O. Chapelle When can semi-supervised learning work? Semi-supervised Learning 2006 MIT Press 2 3
42. G.V. Paolini Global mapping of pharmacological space Nature 24 2006 805 815
43. S. Franzt Drug discovery: playing dirty Nature 437 2005 942 943
44. Z.A. Knight Targeting the cancer kinome through polypharmacology Nat. Rev. Cancer 10 2010 130 137
45. A.L. Hopkins Rapid analysis of pharmacology for infectious diseases Curr. Top. Med. Chem. 11 2011 1292 1300
46. A. Merino Drug profiling: knowing where it hits Drug Discov. Today 15 2010 749 756
47. J.L. Medina-Franco Shifting from the single to the multitarget paradigm in drug discovery Drug Discov. Today 18 2013 495 501
48. M. Reutlinger Neighborhood-preserving visualization of adaptive structure-activity landscapes: application to drug discovery Angew. Chem. Int. Ed. 50 2011 11633 11636
49. M. Reutlinger Multi-objective molecular de novo design by adaptive fragment prioritization Angew. Chem. Int. Ed. 53 2014 4244 4248
50. C.A. Nicolaou, and N. Brown Multi-objective optimization methods in drug design Drug Discov. Today Technol. 10 2013 e427 e435
51. M. Zuluaga Active learning for multi-objective optimization JMLR W&CP 28 2013 462 470
52. B.R. Beno The design of combinatorial libraries using properties and 3D pharmacophore fingerprints Drug Discov. Today 6 2001 251 258
53. T. Meinl Maximum-score diversity selection for early drug discovery J. Chem. Inf. Model. 51 2011 237 247
54. G. Schneider De Novo Molecular Design 2013 Wiley-VCH
55. F. Caschera Automated discovery of novel drug formulations using predictive iterated high throughput experimentation PLoS ONE 5 2010 e8546
56. T.P. Mohamed Active learning for human protein-protein interaction prediction BMC Bioinform. 11 2010 S57
57. B.G. Small Efficient discovery of anti-inflammatory small-molecule combinations using evolutionary computing Nat. Chem. Biol. 7 2011 902 908
58. Y. Lui Active learning with support vector machine applied to gene expression data for cancer classification J. Chem. Inf. Comput. Sci. 44 2004 1936 1941
59. S.A. Danziger Predicting positive p53 cancer rescue regions using Most Informative Positive (MIP) active learning PLoS Comput. Biol. 5 2009 e1000498
60. A.W. Naik Efficient modeling and active learning discovery of biological responses PLOS ONE 8 2013 e83996
61. A. Gaulton ChEMBL: a large-scale bioactivity database for drug discovery Nucleic Acids Res. 40 2012 D1100 D1107
62. P. Schneider, and G. Schneider Collection of bioactive reference compounds for focused library design QSAR Comb. Sci. 22 2003 713 718.